Company intelligence / Profile preview
ASC Therapeutics
Milpitas, California, United Statesasctherapeutics.com ↗
- Ownership
- Private
- Employees
- ~21
- Development stage
- Other
01
Overview
ASC Therapeutics has initiated a Phase I/IIa clinical trial of its lead candidate ASC618 (AAV-based gene therapy) for hemophilia A. The company’s allogeneic cell therapy program ASC930 is in Phase 2 trials targeting acute steroid-refractory graft-versus-host disease. Preclinical programs include therapies for hemophilia B and beta-thalassemia. Early clinical data suggest potential advantages such as lower dosing requirements and improved durability over first-generation therapies
- Therapeutic areas
- HematologyImmunology
- Modalities
- AAV-based gene therapygene therapycell therapy (including allogeneic cell therapy)stem cell therapyCRISPR/Cas9 genome editing
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
University of MassachusettsUniversity of PennsylvaniaStanford UniversityEmory UniversityShantou University Medical College Hospital & Peking University Shenzhen Hospital
Beyond the preview
Go deeper on ASC Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ASC Therapeutics.